LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.32 | 771.67 | 2981 | 10212 | 0.2919 | 0.4372 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 69.32 | 771.67 | 2966 | 10212 | 0.2904 | 0.4353 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.54 | 771.67 | 3053 | 10532 | 0.2899 | 0.4401 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 71.54 | 771.67 | 3037 | 10532 | 0.2883 | 0.4381 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.76 | 771.67 | 3103 | 10851 | 0.2859 | 0.4403 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 73.76 | 771.67 | 3071 | 10851 | 0.2830 | 0.4364 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.02 | 771.67 | 3226 | 11106 | 0.2905 | 0.4504 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 76.02 | 771.67 | 3155 | 11106 | 0.2841 | 0.4420 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.25 | 771.67 | 3253 | 11367 | 0.2862 | 0.4488 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.25 | 771.67 | 3188 | 11367 | 0.2804 | 0.4413 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.48 | 771.67 | 3311 | 11685 | 0.2834 | 0.4499 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.48 | 771.67 | 3177 | 11685 | 0.2719 | 0.4347 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.69 | 771.67 | 3329 | 11974 | 0.2780 | 0.4471 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.69 | 771.67 | 3219 | 11974 | 0.2688 | 0.4349 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.92 | 771.67 | 3359 | 12266 | 0.2738 | 0.4457 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 84.92 | 771.67 | 3210 | 12266 | 0.2617 | 0.4293 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.14 | 771.67 | 3405 | 12592 | 0.2704 | 0.4456 | MN20160304_L01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.14 | 771.67 | 3337 | 12592 | 0.2650 | 0.4383 | MN20160304_L01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.49 | 771.67 | 785 | 867 | 0.9046 | 0.1065 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.49 | 771.67 | 773 | 867 | 0.8908 | 0.0102 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.71 | 771.67 | 873 | 956 | 0.9128 | 0.4896 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.71 | 771.67 | 909 | 956 | 0.9505 | 0.6973 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.94 | 771.67 | 952 | 1045 | 0.9109 | 0.6159 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.94 | 771.67 | 1006 | 1045 | 0.9626 | 0.8330 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.16 | 771.67 | 1030 | 1138 | 0.9047 | 0.6731 | MN20160304_L01 | H17 |